We hypothesized that postcapillary venules play a central role in the control of the tightness of the coronary system as a whole, particularly under inflammatory conditions. Sandwich cultures of endothelial cells and pericytes of precapillary arteriolar or postcapillary venular origin from human myocardium as models of the respective vascular walls (sandwich cultures of precapillary arteriolar or postcapillary venular origin) were exposed to thrombin and components of the acutely activatable inflammatory system, and their hydraulic conductivity (L P) was registered. LP of SC-PAO remained low under all conditions (3.24 Ϯ 0.52 · 10 Ϫ8 cm · s Ϫ1 · cmH 2O Ϫ1 ). In contrast, in the venular wall model, PGE2, plateletactivating factor (PAF), leukotriene B 4 (LTB4), IL-6, and IL-8 induced a prompt, concentration-dependent, up to 10-fold increase in L P with synergistic support when combined. PAF and LTB4 released by metabolically cooperating platelets, and polymorphonuclear leucocytes (PMNs) caused selectively venular endothelial cells to contract and to open their clefts widely. This breakdown of the barrier function was preventable and even reversible within 6 -8 h by the presence of 50 M quercetin glucuronide (QG). LTB 4 synthesis was facilitated by biochemical involvement of erythrocytes. Platelets segregated in the arterioles and PMNs in the venules of blood-perfused human myocardium (histological studies on donor hearts refused for heart transplantation). Extrapolating these findings to the coronary microcirculation in vivo would imply that the latter's complex functionality after accumulation of blood borne inflammatory mediators can change rapidly due to selective breakdown of the postcapillary venular barrier. The resulting inflammatory edema and venulo-thrombosis will severely impair myocardial performance. The protection afforded by QG could be of particular relevance in the context of cardiosurgical intervention. coronary microcirculation; endothelial cells; pericytes; inflammation; thrombosis; polymorphonuclear leucocytes THE CONCEPT OF THE EXISTENCE of a morphological barrier between blood and surrounding parenchymal tissue was introduced more than 100 years ago (45) for the central nervous system. Blood organ barriers hinder free diffusion and/or convective transport of small hydrophilic substances (dyes, nutrients, and drugs) from the blood into the extravasal space or interstitial fluid and prevent the contact of the zymogens of the coagulation system and of many components of the immunological system with the parenchymal cells and tissues around the blood vessels. Classic examples in this respect are the blood brain, blood retina, and blood cerebrospinal fluid barriers (15, 37, 74), the morphological correlate of which is generally believed to be the particularly tight wall structure of the relevant capillaries, which belong to the tightest grade (A-1-␤) in Bennett's traditional classification scale (10).
THE CONCEPT OF THE EXISTENCE of a morphological barrier between blood and surrounding parenchymal tissue was introduced more than 100 years ago (45) for the central nervous system. Blood organ barriers hinder free diffusion and/or convective transport of small hydrophilic substances (dyes, nutrients, and drugs) from the blood into the extravasal space or interstitial fluid and prevent the contact of the zymogens of the coagulation system and of many components of the immunological system with the parenchymal cells and tissues around the blood vessels. Classic examples in this respect are the blood brain, blood retina, and blood cerebrospinal fluid barriers (15, 37, 74) , the morphological correlate of which is generally believed to be the particularly tight wall structure of the relevant capillaries, which belong to the tightest grade (A-1-␤) in Bennett's traditional classification scale (10) .
For the heart, the possibility of a blood-myocardium barrier has not been addressed to date, although evidence thereof has been available for some time. The capillaries of the ventricular myocardium, at least those of the arterial limb of the capillary system, clearly also are type A-1-␤-terminal vessels possessing a continuous basal membrane, endothelium, and a dense pericapillary cellular investment (63, 64, 84) . In contrast to the cerebral capillaries, the myocardial capillaries are not sheathed by astrocytes. However, the highly active coronary endothelial metabolism constitutes, at least for certain substances, an additional, metabolic barrier. Substances initially present in the coronary blood can be degraded rapidly at the endothelial surface (e.g., adenine nucleotides; Refs. 61, 62, 65) ; others are taken up rapidly by the endothelium and metabolized intracellularly, whereby they may be trapped, e.g., by phosphorylation, like adenosine (62) . Whatever the mechanism, such substances, when present in the coronary lumen, do not appear extravascularly.
Studies such as those just cited (79) can also be seen in the wider context of the elucidation of endothelium-mediated vascular responsiveness. The coronary system behaves similarly to other vascular beds in that numerous naturally occurring, hydrophilic vasoactive substances, when present in the blood, function as vasodilators, thus enhancing blood flow, while the same substances when present extravasally function mostly as vasoconstrictors (e.g., paradox reaction of acetylcholine; Refs. 24, 57) . This infers that there is also a barrier to diffusion in the walls of the coronary arteries and arterioles preventing the transmural passage of vasoactive substances under physiological conditions. Indeed, we (63) have shown recently that an intermediate tube, consisting of closely arranged pericytes and their hydrophobic extracellular matrix (ECM), separates the smooth muscle from the endothelium in human ventricular myocardial arteries and arterioles. This intercalated tube, which is intimately associated with the endothelial core tube, may well function as a tight barrier against the diffusion of hydrophilic substances from the coronary lumen to the vascular musculature.
In the myocardial postcapillary venules, a barrier between the blood and the myocardium also presumably exists, although the continuous endothelium of these smallest veins is not invested by a dense, but net-like ECM and pericyte layer (63, 96) . In addition, venular endothelial junctions (19) are generally only loosely organized compared with those of the arteriolar endothelium (84, 85) , and the venular endothelium is apparently able to contract actively and open its junctions widely (52) . Should this occur, as during local inflammatory processes, rapid extravasation of plasma and hence selective recruitment of most of the humoral components of the immunological defense and hemostasiological systems into the interstitial space will result (32) , in turn causing a blockade of the draining venules by fibrin thrombi and hence isolation of the affected area from the rest of the microcirculation. That the centers of inflammatory foci are not perfused is long known, and this fact can now also be explained. The key role in this circulatory "uncoupling" process is played by the subendothelial pericytes in their cocoon of ECM components, which possesses a constitutive, highly prothrombotic potency due to incorporation of abundant tissue factor and prothrombinase (14, 38, 48, 64) . All these complex reactions subserve the concentration and activation of the immune defense in the vicinity of the lesion or focus of infection, thus protecting the rest of the body. Should the defense be inadequate and the inflammation spreads or generalizes, the result will be organ failure due to an insufficient microcirculation. Indeed, reports in recent years have increasingly recognized histologically demonstrable "venuloocclusive processes" (21) , "venular thrombosis" (25) , or "perivenulitis" (35) as the arliest signs of organ failure or allograft rejection, e.g., rejection of transplanted hearts (72) .
Against the foregoing background we developed the following working hypothesis. First, a comprehensive vascular barrier between the blood and the parenchyma of an organ will necessarily reflect the integrated barrier features of all microcirculatory segments. The presence of tight capillaries is a necessary, but alone not sufficient, prerequisite for a bloodorgan barrier. Second, while the tightness of arterioles and type A-1-␤ capillaries depends critically on tight junctions and the pericyte cocoon, i.e., primarily on more-or-less static cell biological characteristics and physical properties, that of the venules depends on the rapidly changeable contractile state of the venular endothelium. Third, with the appearance of inflammatory mediators in the microcirculation of an organ with a normally tight barrier in all microcirculatory segments, as in the ventricular myocardium, it is the reaction of the postcapillary venular barrier that will decisively determine the clinical prognosis.
In the present study, key aspects of this working hypothesis were examined experimentally with respect to the heart using novel in vitro models of the precapillary arteriolar and postcapillary venular vessel walls derived from human ventricular myocardium (63) . Activated and metabolically cooperating platelets and polymorphonuclear leucocytes (PMNs) induced breakdown of the barrier function [as reflected by the hydraulic conductivity (L P )] only in the venular wall model. The flavonoid compound quercetin-3-O-␤-D-glucuronide (QG) obviated this damage, even in the continued presence of the blood cells. Extrapolating these findings to the myocardial microcirculation in vivo implies strongly that the tightness and multifunctionality of the latter under numerous clinically relevant conditions can change rapidly (and threateningly) primarily due to the high degree of reactivity of the venules. The protective action of QG is of particular relevance in the context of cardiosurgical interventions and preservation of explanted organs.
MATERIALS AND METHODS
All experiments on explanted hearts and vascular cell cultures of human myocardial origin were done with written informed consent of the patients and with approval of the ethical committee of the Ludwig Maximilians University of Munich according to the principles expressed in the Declaration of Helsinki.
Materials
Polymorphoprep was supplied by Axis-Shield (Oslo, Norway); lipoxin A 4 and PGE2 were purchased from Biomol (Hamburg, Germany); plasma substitute Biseko was supplied by Biotest (Dreieich, Germany); QG was obtained from Boehringer Ingelheim (Ingelheim, Germany); 6-[6-(3R-hydroxy-1E,5Z-undecadien-1-yl)-2-pyridinyl]-1,5S-hexanediol (U-75302) was obtained from Cayman chemical (AnnArbor, MI); Transwell polyethylenterephthalat culture supports with a surface area of 4.5 cm 2 , a pore size of 0.4 m, and a pore density of 10 8 /cm 2 were from Corning (Corning, NY); rofecoxib was commercially available from Forest Laboratories (New York, NY); Percoll was bought from GE Healthcare Europe (Freiburg, Germany); DMEM, FCS, streptomycin, penicillin, balanced salt solution (BSS), PBS, and trypsin/EDTA solution were purchased from Invitrogen (Karlsruhe, Germany); platelet-activating factor (PAF)-16-antagonist was obtained from Merck Biosciences (Bad Soden, Germany); tissue culture solution endothelial cell growth medium was supplied by Promocell (Heidelberg, Germany); adenosine deaminase, collagenase D, and dispase I were obtained from Roche Diagnostics (Mannheim, Germany); 60 U/mg trypsin were purchased from Serva (Heidelberg, Germany); Ficoll 70, Fast Blue BB, Fast Red TR, naphthol-AS-MXphosphate, Fast Blue B, gly-Pro-4-methoxy-␤-naphthylamide, acetylsalicylic acid (ASA), H 2O2, IL-6, IL-8, PAF-16, arachidonic acid (AA), leukotriene leukotriene B4 (LTB4), FMLP, recombinant human complement factor C5a, human thrombin, LPS, glutaraldehyde, and OsO 4 were from Sigma (St. Louis, MO).
Histological Techniques
Tissue fixation. IMMUNOHISTOCHEMISTRY. tissue cultures were prefixed for 2 min at room temperature by immersion in 4% paraformaldehyde (PA) in PBS, stored overnight in PA at 4°C, permeabilized with 1% Triton X-100 in PBS for 30 min, and washed with PBS. ENZYME HISTOCHEMISTRY. cell cultures were treated for 30 s with glutaraldehyde/PA and 15 min in PA followed by three washings in PBS; heart ventricles were perfused with the same fixatives for analogous periods.
Staining techniques. F-actin in endothelial cells was visualized by fluorescent phalloidin (Sigma); alkaline phosphate and dipeptidyl aminopeptidase IV activity was visualized histochemically using standard procedures (7, 100) .
Time-lapse videomicroscopy. The isolation of pure postcapillary venules is described in detail elsewhere (63) .
Endothelial cells and pericytes derived from such preparations were seeded in circular spots (3-to 4-mm diameter) in a 6-cm diameter Petri dish. After 2 wk, large and homogenous endothelial colonies developed (Ͼ1 cm diameter), which were typically surrounded by pericytes (63) . Such dishes were supplied with fresh culture medium and mounted within a custom-built incubator on the stage of an Axiovert 200 microscope (Zeiss, Göttingen, Germany). Time-lapse video recordings of cellular interactions on venular endothelial cell cultures were started after 1 day in complete darkness under dimmed, yellow light (maximal light absorbance ϳ430 nm). An automatic shutter device prevented continuous illumination of the cultures during longer (Ͼ2 h) recordings.
Preparation of Sandwich Cultures of Endothelial Cells and Pericytes of Precapillary Arteriolar and Postcapillary Venular Origin
The establishment of the sandwich cultures is described in detail elsewhere (63) . In brief, the smallest arteries and veins from ventricular myocardium of human explant hearts (freshly obtained in the course of heart transplantations; their isolated tips were perfused via cannulae fixed in the main coronary arteries) were dissociated proteolytically under aseptic conditions using essentially the experimental approach described earlier (66) and our own dispersion and separation techniques (63) . The microvessels were fractionated by isotonic Percoll density gradient centrifugation. Highly purified venules and arterioles were obtained at buoyant densities of 1.058 Ϯ 0.005 and 1.050 Ϯ 0.005 g/cm 3 respectively. Arteriolar harvests were first cultivated for 4 days in human endothelial serum-free media basal growth medium (GIBCO/Sigma) supplemented with 10% FCS (vol/vol), 200 U/ml penicillin, 0.2 mg/ml streptomycin, 1 g/ml fibronectin, 10 ng/ml EGF, and 20 ng/ml basic FGF. Subsequently, the cultures were incubated to confluence in a 1:1 mixture of DMEM and endothelial growth culture, which had been adjusted to 6% (vol/vol) FCS and was supplemented with penicillin and streptomycin ("mixed medium").
Cell and vessel fragments of venular origin were cultivated from the beginning until confluency in same mixed medium.
Purified colonies of venular or arteriolar endothelial origin were detached with a minimum amount of trypsin/EDTA, diluted with a 10-fold higher volume of mixed medium and seeded into Transwell inserts (ϳ10 5 cells/cm 2 ), and cultivated under standard conditions (37°C, PCO2 ϭ 40 mmHg, water-saturated atmosphere). One day later, smaller numbers of pericytes (ϳ5·10 3 cells/cm 2) were seeded on the lower surface of the polyethylenterephthalat membrane basically as described by Nakagawa et al. (60) . Cultivation of these sandwich cultures proceeded for 5 days in mixed medium before the insets were inserted into the filtration apparatus (see below).
Preparation of Blood Cells and Cell-Free Supernatant
Isolation of PMNs. Aliquots (5 ml) from 50 ml freshly drawn citrated blood from healthy donors (who had refrained from taking any medication for Ն2 wk) were layered on 5 ml Polymorphoprep solution and centrifuged according to the supplier's instructions. The purified PMN bands were aspirated, combined, and diluted with BSS. After low-speed centrifugation at 800 g, the pellet was resuspended in a mixture of 2 ml BSS and 0.5 ml autologous citrated plasma.
Isolation of platelets. Cells from 10 ml freshly prepared plateletrich plasma were centrifuged at 600 g through isotonic Percoll solution (specific density d 1.05 g/ml, pH 7.4) supplemented with 100 M adenosine. Platelets concentrated in a band on top of 1 ml of isotonic Percoll solution (d ϭ 1.10 g/ml), which had been underlayered before centrifugation. This band (ϳ0.5 ml) was aspirated and diluted to a final volume of 2.5 ml with BSS supplemented with 2 IU adenosine deaminase to degrade the platelet inhibitor adenosine. Platelets (and also PMN) were used within 2 h.
Isolation of erythrocytes. These cells were purified according to Beutler et al. (11) .
Preparation of standardized supernatant of activated PMN/platelets. CaCl 2 (2 mM), FMLP (10 M), and ADP (100 M) were added after mixing equal volumes of the above preparations of purified PMNs and platelets (final cell concentrations: PMN, 4,400/l Ϯ 10%; platelets, 70,000/l Ϯ 10%). The suspension was incubated at 37°C for 10 min, centrifuged at 15,000 g for 10 min, and filtered (sterile filter, 0.2-m pore size). Dilutions (1:10) of this solution with basal filtration medium containing 5% Ficoll 70 (see below) were used routinely to induce a prompt massive breakdown of venular endothelial cell barriers in many of the experiments.
Measurement of L P in the Presence of Pharmacological Inhibitors
The preparation of sandwich cultures of constituent precapillary arteriolar or postcapillary venular wall cells and the measurement of LP of these microvascular wall models in a custom-made apparatus are described in detail elsewhere (63) .
The blood cell suspensions (preparation see above), chemical solutions, or solutions with PMN/platelet release products to be brought into direct contact with the adapted endothelial barriers of Transwell cultures (4 ml in all cases) were mixed with 1 ml 25% (wt/vol) solution of Ficoll 70 in filtration medium (the latter was prepared by mixing 7 vol serum-free endothelial cell growth medium with 3 vol Biseko. Before use, this mixture was dialyzed extensively against freshly prepared human citrate plasma supplemented with 10,000 U/ml penicillin and 10 g/ml streptomycin. Finally, the dialysate was adjusted to a concentration of free calcium ions of 4 mM, centrifuged for 1 h at 15.000 g, and sterilized by filtration). The above samples were then layered slowly onto the confluent endothelial sheets on their filter membranes. To inhibit cyclooxygenase-1 (COX-1) activity in endothelial cells, a 500-M ASA solution was overlayered on endothelial barriers for 30 min and then filtered through the cell layer. COX-1 in platelets was inactivated by addition of 500 M ASA for 30 min to the suspensions, the latter were either brought in contact with endothelial barriers directly or after transfer of platelets in ASA-free BSS. To inhibit COX-2 activity in endothelial barriers, the latter were preincubated with 50 M rofecoxib for 30 min. To Transendothelial flow was measured continuously using a sensitive electronic balance (Sartorius, Göttingen, Germany; type: ultramicro-ME) and recorded online. After an initiation phase of 10 min, measured flow rates under all conditions tested were constant for Ն20 min and proportional to the concentration of inflammatory mediators in the filtration medium.
Synthesis of Various Pharmacological Inhibitors by Sui Laboris
ZD2138 (a 5-LOX inhibitor; CAS no. 140841-32-3) was synthesized according to the ICI Patent 0385662 (1990), and rofecoxib (a COX-2 inhibitor; CAS no. 162011-90-7) according to Merck Frosst Canada, Patent WO 9608482. BAY-X-1007 (FLAP, a 5-LOX-activating protein inhibitor) was synthesized with slight variations according to a method derived from patent DE3900261A1. In brief, after protection of the hydroxy function of 4-hydroxyphenyl acetic acid methyl ester by reaction with benzyl chloride, the methylene group of the intermediate was alkylated by cycloheptyl bromide, yielding (4-benzyloxy-phenyl)cycloheptyl acetic acid methyl ester. After hydrogenolytic removal of the protecting group, the hydroxy group was esterified by 2-chloromethyl quinoline hydrochloride, forming [4-(quinolin-2-yl-methoxy)-phenyl]-cycloheptyl acetic acid methyl ester. The final step was cleavage of the ester to give the free acid, [4-(quinolin-2-yl-methoxy)-phenyl]-cycloheptyl acetic acid. Since the intermediate products could not be isolated as precipitates after addition of water, they were isolated by extraction with ethyl acetate after adjusting the pH to 5.5.
Assay of LTB 4, PGE2, and PGI2
These assays were carried out in duplicate in coculture supernatants using commercially available ELISA kits (Cayman Chemical, Milan, Italy) following the manufacturer's instructions.
Histological Demonstration of Platelets and PMNs in the Microvasculature of Isolated Perfused Human Heart Tips
Prewarmed human heart tips (from surgically rejected hearts of donors of known blood group) prepared as described elsewhere (63) were perfused for 30 min with Krebs-Henseleit medium and then circumfused with 100 ml of the commercially available plasma substitute "Biseko" for 30 min at 37°C. This protocol was repeated with a fresh batch of 100 ml Biseko for another 30 min. Thereafter, 10 ml of standardized supernatant of activated PMNs/platelets were diluted with 100 ml Biseko and circumfused for 10 min. Following subsequent admixture of 110 ml group-matched heparinized whole blood and addition of ADP (100 M) and FMLP (1 M) to activate platelets and PMNs, circumfusion was continued for further 30 min. Thereafter, a concentrated solution of Evans blue in 25 mM HEPES-buffered Earle's salt solution without calcium was added to the reservoir until the perfusate turned intensively blue, and the procedure was continued for another 2 min so as to demarcate the perfused myocardial areas. Subsequently, these were dissected, immediately cut into small cubes (ϳ100 mm 3 ) , and frozen in liquid nitrogen. All enzymatic histochemical stainings were performed in 40-m-thick cryopreserved sections, which were postfixed for 5 min. Platelets were primary labeled with monoclonal (BL-E6) anti-CD 61 (Sigma) and PMNs with monoclonal (BM-2) anti-PMN (MBL, Nagoya, Japan). Immunological staining was performed using alkaline phosphatase-linked anti-mouse IgG antibody and azo dye coupling components Fast Blue BB (blue dye) or Fast Red TR (brick red).
Statistical Analysis
Data are presented as means Ϯ SD. Comparisons of group data were performed using a one-way ANOVA followed by the StudentNewman-Keuls post hoc test. P Ͻ 0.05 was considered significant.
RESULTS

Influence of Various Activated Blood Components on the L P of Microvascular Wall Models
Basic experiments on sandwich cultures of precapillary arteriolar (SC-PAO) or SC-PVO showed that the L p of SC-PVO is determined mainly by the confluent endothelial tissue; a physical influence of their wide-meshed cellular net of pericytes on the hydrodynamic resistance was insignificant (63) . In contrast, in the arteriolar wall model the pericyte layer contributed substantially to the tightness (and correspondingly low L P ), very probably via the organization of a continuous ECM along their entire basal surface, which opposed the coordinated endothelial sheet. Figure 1 , lane a, shows that model vessel walls of precapillary arteriolar origin (SC-PAO) are indeed much "tighter" (lower L P ) than those cultured from postcapillary venules (SC-PVO) of the same hearts under basal conditions (L P of SC-PAO: 3.24 Ϯ 0.52·10
While the L P of SC-PAO did not change significantly under any of the various additional conditions (Fig. 1 , lanes b-e, l, and m), that of SC-PVO changed substantially depending on the incubation conditions. As is evident from Fig. 1 , lane b, thrombin, the key enzyme of coagulation, even at the high concentration of 1 IU/ml, did not increase L P of pure cultures, which were those normally investigated (see also Supplemental Video S1; Supplemental Material for this article is available online at the Am J Physiol Heart Circ Physiol website). The L P increased considerably and concentration dependently, however, in response to thrombin if the endothelial sheets were contaminated by Ͼ3% pericytes (Fig. 2) . Microscopic inspection revealed occasional thrombin-induced contraction of individual pericytes, resulting in "holes" in the endothelial sheet. No changes in L P were observed when SC-PVO were exposed to ADP-activated platelets (Fig. 1, lane c) . FMLP-activated PMN (cell density 10-fold higher than venular endothelial cells), however, induced an approximately twofold increase of L P (Fig. 1, lanes d and e) but only when activated in the presence of 10 M H 2 O 2 (which itself, like FMLP, had no effect on L P ). The L P response of SC-PVO to activated PMN/ H 2 O 2 was abolished by antioxidants such as uric acid (Fig. 1,  lane f) or QG (Fig. 1, lane g ). In contrast, in the presence of 100 nM AA (which itself had no prompt effect on barrier function), the deleterious effect of FMLP/H 2 O 2 -activated PMN (analogous cell densities as in the experiments before) on L P was increased twofold (Fig. 1, lane h) , and, after additional application of PAF, an important mediator of inflammation (104) , L P increased four-to fivefold (Fig. 1, lane j) compared with untreated cultures (Fig. 1, lane a) . Neither of these effects could be prevented by antioxidants (such as uric acid and vitamin C; Fig. 1, lanes i and k, respectively) . The fastest breakdown of the SC-PVO was observed after exposure to simultaneously activated platelets and PMNs (platelet density 30-fold that of the PMN; Fig. 1 , lane l, see also Supplemental Videos S2-4). Similar changes in SC-PVO L P were induced by exposure to the standardized supernatant of the simultaneously activated platelets and PMNs (Fig. 1, lane m) . Figure 3 shows a series of phase-contrast images from a time-lapse recording (see MATERIALS AND METHODS) of the reactions of a human coronary endothelial cell islet (surrounded by pericytes not visible in the frames) during some of the above, almost identical incubation conditions. Additions were made Fig. 2 . Influence of thrombin and contaminating pericytes on the hydraulic conductivity (LP) of SC-PVO. OE, SC-PVO with pure endothelial tissue and a loose pericyte network on the contralateral surface of the filter. , Similar experiments on sandwich cultures in which the endothelial cell layers were contaminated by ϳ3% pericytes. Data are means Ϯ SD; n ϭ 4. Fig. 3 . Reactivity of cultured human endothelium of postcapillary origin. Specific reactions of venular endothelial cell (VEC) to activated blood components and to QG are reflected in the endothelial tissue architecture, which is constantly remodeled under control conditions. Additions were made successively, i.e., the previously added components remained in the chamber. A: control. B: after 3-min exposure to thrombin (1 IU/ml). C: 30 min after addition of unstimulated PMNs (ϳ1/1 VEC), which initially appeared as loosely attached, golden corpuscles predominantly at the apical endothelial surface (some are marked by red arrows). D: 2 PMNs (red arrows) transmigrate the endothelial layer via an intercellular junction (white arrow). Four successive exposures were taken at 5-min intervals. E: activated PMNs 15 min after addition of FMLP; the leucocytes (red arrows) that had emigrated are following the chemotactic gradient of their activator and are migrating back to the incubation medium (watch Supplemental Video S3). F: 15 min after the addition of platelets (small, unattached ellipsoid corpuscles predominantly along the endothelial clefts), many venular endothelial cells are contracted and a widespread disruption of their clefts is evident; the frames 1 and 2 in f are shown enlarged in G, individual platelets (black corpuscles) within enormously opened endothelial clefts (encircled by dotted blue lines) adhere to the substratum but do not aggregate. H: 60 min after the addition of QG individual endothelial cells are relaxed and flattened again and their junctions are almost completely reclosed. I: enlarged frames 1 and 2 from h. Phase-contrast micrographs (A-I) are discrete frames from time-lapse video sequences included in Supplemental Videos S1-5.
successively without removing the prior supplements. Endothelial tissue grown under optimized and strictly standardized conditions, i.e., unperturbed, showed the typical paving-stonelike tissue architecture (Fig. 3A) , which remained similar to control during exposure to thrombin (Fig. 3B ), nonactivated PMNs (Fig. 3, C and D) , and PMNs activated with FMLP in the absence of H 2 O 2 (Fig. 3E) . Many PMNs transmigrated soon after their contact with endothelial cells into the subendothelial space, and the detailed behavior of two of them is shown in Fig. 3D . The addition of the formylated peptide, however, increased the amoeboid motility of the PMNs about fivefold (1.3 Ϯ 0.2 vs. 6.2 Ϯ 0.9 m/min), and all leucocytes rapidly followed the chemotactic gradient of their activator and migrated quickly back into the incubation medium. The addition of platelets caused the intercellular clefts to open promptly (Fig. 3, f and g ). This breakdown of the endothelial barrier was reversed by the addition of QG (Fig. 3, h and i) despite the continued presence of thrombin and activated PMNs and platelets. The complete time-lapse recordings are available in Supplemental Videos S1-5. Figure 4 demonstrates the assembly of F-actin in sheets of human postcapillary venular endothelial cells (again cocultured with surrounding pericytes, not visible) as revealed after being washed, fixed with formaldehyde, permeabilized with Triton X-100, and stained with fluorescent phalloidin (red). In the presence of activated platelets and PMNs (Fig. 4, C and D) , the degree of actin polymerization in venular endothelial cells is increased substantially compared with quiescent cells with their typical thick cortical actin ring (Fig. 4, A and B) . Following incubation with 50 M QG for 2 h, the F-actin in the endothelial cells was, however, completely disaggregated. Using a longer (eightfold) exposure time in these images to document the weak actin fluorescence of these cells (Fig. 4, E and F) shows that the activated PMNs (some marked by white arrows in Fig. 4F ) appear as brightly fluorescent corpuscles despite their low concentration of actin (10% of that of resting endothelial cells under standard conditions) and the actin in the leucocytes remained in the polymerized form. The actin systems in control endothelial cultures also disassembled completely on incubation with QG (50 M; Fig. 4G ). With respect to Fig. 4 , it must be noted that the unavoidable preparation and fixation of venular endothelial cells for these studies led frequently to a final contraction and hence distinct gap formation between these highly reactive cells. At first glance, this may erroneously create the impression that the starting cell layer was either not tight or nonconfluent or that QG did not tighten the tissue barrier in such experiments.
Pharmacological Studies
To gain deeper insight into the metabolical and cellular origin of the release products of the activated blood cells in SC-PVO, the cocultures were incubated with various specific inhibitors (Fig. 5, lanes a-l) . These experiments were based on considerations relating to metabolic cooperation between en- dothelial cells, platelets, PMN, and erythrocytes (see Fig. 11 for summary).
The observed breakdown of the SC-PVO barrier in the presence of simultaneously activated platelets and PMNs or their supernatant (Fig. 5, lanes b and c, respectively) could be blocked almost completely when platelets were preincubated with ASA (500 M) before addition to SC-PVO (Fig. 5, lane  d) . In contrast, pretreating the PMNs with ASA and then coculturing them with platelets in SC-PVO had no acute inhibitory influence on L P (data not shown). While the effect of the L P -increasing platelet/neutrophil-release products in the supernatant of the blood cells could not be inhibited by addition of ASA (Fig. 5, lane e) , the addition of PAF antagonist (Fig. 5, lane f) or inhibitors of leukotriene synthesis (Fig. 5,  lanes g and h) to SC-PVO in presence of the supernatant from prestimulated platelets and PMNs had also no statistically relevant effects. In contrast, addition of the LTB 4 receptor antagonist U-75302 attenuated the L P increase significantly (Fig. 5, lane i) . The tightness (lowering of L P ) of the venular wall models increased further when U-75302 was added together with the PAF antagonist (Fig. 5, lane j) . On the other hand, 100 mol/ml QG proved to be a very effective inhibitor of L P increases, not only in SC-PVO incubated with platelets and PMNs (Fig. 5, lane k) , but also, in sharp contrast to ASA, in SC-PVO jeopardized by the addition of the supernatant of the activated blood cells (Fig. 5, lane l) . QG itself did not influence basal barrier function (Fig. 5, lane m) . Figure 6 shows the concentration dependency of the inhibitory effect of ASA and QG on platelet/PMN-supernatant-induced increases of L P (curves at the right) and similar experiments with lipoxin A 4 (LXA 4 ) which reached maximum inhibitory potency at 1 M (left). Interestingly, the concentration/response curve of QG (but not that of ASA, data not shown) was shifted in the presence of 10 nM LXA 4 to lower concentrations (central curve) by about an order of magnitude (synergism). Figure 7 shows the time dependency of QG-induced repair processes in SC-PVO that had been completely opened by prior incubation with the supernatant of simultaneously activated platelets and PMN. After ϳ6 -8 h, such layers revealed again the typical tightness of resting venular endothelium. In the controls, the endothelial barrier remained open (the initial L P even increased), and occasionally the venular endothelial cells detached from their substratum.
Influence of ASA and QG on Platelet/PMN-Induced Increases of L P of SC-PVO and the Effect of Lipoxin A 4
Influence of Various Mediators of Acute Inflammation on the L P of SC-PVO
L P of SC-PVO increased characteristically and concentration dependently on exposure to various lipid and peptide mediators of acute inflammation, some of which cooperated synergistically with respect to opening of these postcapillary venule barriers in vitro (Fig. 8 ). In combination with LTB 4 , minimum concentrations (3 nM) of both PAF and PGE 2 (separately or in combination) shifted the concentration/effect curve for LTB 4 synergistically by almost an order of magnitude to lower concentrations (Fig. 8, top) . Similarly, IL-6 and IL-8 caused a concentration-dependent loss of barrier function and acted synergistically with LTB 4 (Fig. 8, bottom) .
Influence of Various Inhibitors on the Release of Eicosanoids During the Metabolic Cooperation between PMNs and SC-PVO in the Presence of AA and PAF
The foregoing experiments with inhibitors suggest that the release products from activated platelets, most probably AA and PAF, stimulate the synthesis and release of a leucotriene from simultaneously present activated PMNs. To gain insight into the eicosanoids actually released in the vessel wall model under such incubation conditions, SC-PVO were first preincubated for 4 h in medium containing the supernatant from activated platelets and PMNs, thus mimicking acute inflammatory conditions. The incubation was then continued in fresh medium (filtration medium) in the presence of PMNs and the typical platelet release products AA (20 M) and PAF (100 nM). The release of LTB 4 , PGI 2 and PGE 2 could be demonstrated; addition of inhibitors of eicosanoid synthesis had the expected characteristic effects (Fig. 9) .
Further experiments revealed that red blood cells also played an important role in these transcellular metabolic interactions (results not shown in Fig. 9 ). In the presence of these cells (1,000-fold greater density than the PMNs in the mixed cultures), trace amounts of cysteinyl leucotrienes (Ͻ30 pg/ml) such as LTC 4 were no longer detectable in the incubation medium of activated SC-PVO and PMN, but the concentration of LTB 4 measured in the presence of erythrocytes was roughly fourfold that in the absence of these cells (compare with Fig. 9B ). 
Segregation of Activated Platelets and PMNs and the Protective Effect of QG in the Inflamed Microvasculature of Isolated Blood-Perfused Human Hearts
Enzyme histochemical discrimination of arterioles and venules and immunologic staining of PMNs and platelets in three human hearts revealed selective segregation of PMNs in the venules and their surrounding interstitium (Fig. 10, A and  B) and of platelets in the corresponding arterioles (Fig. 10, A  and B) after circumfusion of the ventricular coronary system with matched whole blood for 10 min. To activate the two blood cell species maximally and simultaneously, 100 M ADP and 1 M FMLP were added to the blood. Similar results were obtained in two further hearts in which only exogenous ADP was added to activate the platelets selectively (micrographs not shown). The release products of these cells also promptly activated the PMN. In contrast, accumulation of platelets as well as PMNs was practically absent when 100 M QG was added to the recirculated blood (followed after 5 min) by addition of 100 M ADP and 1 M FMLP (3 hearts, Fig.  10E ). However, FMLP-activated PMNs could still be recruited from coronary venules into the myocardial interstitium of reperfused human heart tips (Fig. 10F) .
DISCUSSION
In the present study, sandwich cultures of the constituent cells of human myocardial arteriolar and venular vessel walls and a custom-made filtration system (63) allowed acute inflammatory processes to be modeled in vitro. Pharmacological and biochemical studies were employed to elucidate the participating mechanisms and to characterize potential means for therapeutic intervention.
Studies on the Hydrodynamic Resistance of Cultured Microvascular Tissue Barriers
The baseline L P of sandwich cultures of endothelial cells and pericytes of postcapillary venular origin (SC-PVO), 2.55 Ϯ 0.32·10 Ϫ7 cm·s Ϫ1 ·cmH 2 O Ϫ1 (n ϭ 10), was consistent with the L P of intact venules in vivo (39, 67, 73) . The basal L P of analogous tissue barriers of precapillary arteriolar origin (SC-PAO), 3.24 Ϯ 0.52·10 Ϫ8 cm·s Ϫ1 ·cmH 2 O Ϫ1 (n ϭ 37), was about an order of magnitude lower, presumably reflecting both the higher degree of organization of the intercellular junctions of the arteriolar endothelium (84, 85) and the presence of a thick and continuous ECM organized by the subendothelial arteriolar pericytes (63) . The characteristically low L P of the precapillary arteriolar vascular barrier in vitro did not change significantly under any of the subsequent experimental conditions and remained consistent with that reported for the tight arterioles of the rat brain and mesentery (39, 40) .
As is typical for isolated venules from human myocardium, SC-PVO possessed a wide-meshed pericyte network with an only weakly developed ECM. The barrier properties in this model (63) thus presumably reflected primarily the properties of the contractile endothelium. In contrast to the SC-PAO, the L P of the venular model, relatively low under basal, quasiphysiological conditions, proved to be highly dependent on the composition of the incubation medium.
Influence of thrombin. Even high concentrations of thrombin (1 U/ml; full activity in culture medium containing the plasma derivative Biseko instead of FCS) had no permeability-enhancing effect on SC-PVO. This finding is consistent with the observation that acute exposure to a very high thrombin concentration (10 U/ml) does not increase venular permeability in situ but only after 24-h adaptation of the microvasculature to locally developing inflammatory reactions (17) . A plausible explanation for this observation may be deduced from our findings relating to the influence of inflammatory cells and mediators on the wall tightness of the venular wall model (see below). 1) The observed lack of influence of thrombin on the barrier function of SC-PVO is in clear contrast to many studies This phase-contrast image shows adherent PMNs ready for diapedesis inside these vessels (some marked by white arrows) and in addition many emigrated leukocytes accumulating in the interstium (black arrows). C and D: immunohistochemical staining for platelet aggregates (blue) selectively within the smallest arterioles (brick-red staining for AP) and the respective postarteriolar capillaries. C: overview, the unstained postcapillary venules contain no platelet aggregates and hence appear relatively "empty" (area within the dotted green line). D: region in the vicinity of an arteriole at high magnification. Individual PMNs are now visible (violet). Many emigrating PMNs accumulate around the otherwise unstained venules, the brick-red arterioles in their vicinity are free of these leucocytes. E and F: similar histochemical studies in the presence of QG (stains analogous to C and D). E: aggregates of platelets cannot be detected in the arterioles. F: emigrated PMNs (violet) after activation with FMLP. (27, 59) in which thrombin has been used successfully to enhance endothelial permeability in vitro. One explanation for this discrepancy might be that the endothelial barriers studied during those investigations contained admixtures of contaminating cells that contract on contact with thrombin. As seen in Fig. 2 , the presence of very few pericytes (3% of the total cell number) is sufficient to elicit large changes in permeability of the entire endothelial sheet. 2) Other reasons for the observed discrepancy can be deduced from the fact that we employed new culture techniques. Sandwich cultures of human arteriolar and venular endothelial cells with their corresponding pericytes (63) provide local growth conditions for the isolated endothelial cells which mimic the situation in vivo more closely.
3) Yet a further contribution to the discrepancy between our observations and the literature cited is that endothelial cultures grown in serum-containing media already show signs of inflammatory activation, such as elevated expression of dipeptidyl aminipeptidase IV, leucocyte adhesion molecules such as ICAM-1, polymerized smooth muscle ␣-actin, and an increased L P (63) . Serum in fact contains many inflammatory mediators (release products of activated platelets and leucocytes, activated coagulation factors, etc.). In the present study, we therefore cocultured exclusively homogenous sheets of endothelium and pericyte-networks and preincubated these "sandwich-filters" in a serum-free medium that contained a human plasma derivative without coagulation factors or isoagglutinines for 2 days before the experiments.
Influence of platelets. Platelets have been regarded in the literature as promoters of high vascular tightness (88) , and the tightness of our sandwich cultures in presence of platelets was indeed similar to control (see Fig. 1, lane c) . In contrast, in the mouse, a key role for activated platelets as inducers of a higher permeability of lung endothelium and a concomitant leakage of plasma proteins has been reported (89, 102) . The behavior of platelets, however, depends critically on the balance between platelet-activating and platelet-inhibiting substances in their immediate vicinity. In the present experiments, they were activated with ADP, which is rapidly metabolized by venular endothelial ecto-phosphatases to adenosine, a potent platelet inhibitor (29, 62, 65) . Adenosine accumulation at the endothelial surface might therefore have been causally involved in the protection of the postcapillary endothelium.
Our histological studies in isolated perfused, human heart tips show platelet aggregation only in the arterioles. The released ADP, together with the exogenous ADP, is presumably again degraded to adenosine during the passage through the capillary bed, resulting in a high adenosine concentration in the venules. The selective accumulation of ADP-induced platelet aggregates in the arterioles might be explained by the expression of specific, shear force-dependent platelet receptors on the arteriolar endothelium (3, 94) . Moreover, cultured human endothelial cells of arteriolar origin contain, in contrast to those of venular origin, particularly high numbers of Weibel-Palade bodies (63) . The content of these secretory organelles (56) is dominated by the hemostatic factor von Willebrand factor antigen (vWF:Ag), which strongly promotes platelet adhesion to the vessel wall (20) .
Influence of PMNs. PMNs have been regarded frequently as being responsible for oxidative vascular damage, which leads to increased permeability (33, 36, 89) , particularly after ischemia/reperfusion (69, 71, 103 ). However, we were able to demonstrate such an effect only when the leucocytes had been incubated together with exogenous H 2 O 2 (which itself had no influence), thereby enhancing their potency for the formation of reactive oxygen species (ROS). A similar dependency has been reported for PMN, which are thought to cause postischemic dysfunction of isolated perfused hearts via formation of hypochlorous acid in the simultaneous presence of thrombin and H 2 O 2 (69) .
In our hands, however, accumulation of ROS could be prevented completely by uric acid, vitamin C, or quercetin glucuronide. Uric acid is a typical release product of endothelial cells (61, 62) , its physiological plasma concentration (ϳ100 M) is very high, and it is a very powerful antioxidant (8) . The pathogenetic significance currently attributed to ROS and nitric oxidde (NO) metabolites may thus be overestimated.
Influence of simultaneously activated platelets and PMNs. The permeability-enhancing effect of highly purified PMNs was potentiated in the presence of H 2 O 2 and exogenous AA (typically released by activated platelets), and the increase in L P could not be prevented by antioxidants. This effect of AA was promoted by addition of PAF.
The most dramatic increases in SC-PVO L P , however, occurred during their interaction with concurrently activated platelets and PMNs (Supplemental Video S4). Coupling between leucocyte/platelet activation and microvessel permeability, thrombosis, and inflammation in vivo is attracting increasing interest and is subject of several excellent reviews (33, 47, 90) . Studies (51, 52) using silver staining have demonstrated directly selective and uniform opening of postcapillary venular endothelial junctions under the influence of inflammatory mediators. These substances might well be mainly release products from activated platelets and PMN, such as PAF and LTB 4 (see below). As noted above, this could then explain why the postcapillary venular barrier breaks down (17, 51) when these acutely activatable blood cells accumulate in inflamed microcirculatory regions and are then exposed to thrombin, the most potent natural platelet activator.
Contractility of Venular Endothelial Cells, Loss of Their Barrier Function, and Specific Pharmacological Intervention
The observed wide and general opening of junctions during contraction of venular endothelial cells with involvement of polymerized ␣-actin is consistent with other studies (13, 26, 43, 91, 95) . The quiescent endothelial phenotype is characterized by a thick cortical actin ring. Stress fibers are practically absent. In contrast, the activated cell phenotype expresses abundant stress fibers and only little or even no cortical actin. A whole plethora of inflammatory events triggers this reorganization, whereby the phosphorylation of the myosin light chain (MLC) is considered to be centrally important and directly correlated with the state of contractility. The latter depends not only on the activity of a specific myosin light chain kinase (MLCK; Ref. 82) , but also of the activity of the corresponding phosphatase (MLCP). This enzyme activity is tightly coupled to activated RhoA, which enhances the phosphorylation of the phosphatase regulatory subunit via a special Rho kinase (9) . This kinase itself can also phosphorylate MLC (2) . The current paradigm holds that the tightness of an endothelial barrier is maintained by the finely tuned equilibrium between the forces providing centripetal tension (actomyosin contraction depending on stress fibers) and the centrifugal forces, which rely on several cytoskeletal components coupled to the cortical actin ring. The latter is necessary for the establishment of intercellular adhesion and the maintenance of endothelial barriers (13) . Some of them are represented by adhesion molecules, which provide cell-cell and cell-substrate attachments. Of particular interest in this context is our observation that both activated and quiescent venular endothelial tissue lose their typical actin systems during incubation with QG and simultaneously develop surprising tightness (i.e., low L P , compare Fig. 5, lanes k-m) . Interestingly, another study (1) has raised the possibility that, in addition to the assembly and complex regulation of the actin/myosin system, certain factors may contribute to the opening of endothelial clefts of isolated venules in response to inflammatory mediators such as PAF and bradykinin. In that study, it was suggested that there are extensive subpopulations of endothelial cells that regulate the width of the intercellular clefts by varying the conformation of specific adhesion molecules. The mode of action of QG will, however, remain unclear until the signal transduction cascade has been fully elucidated.
The contractility of the venular endothelium has long been recognized (26, 31, 41) , and although studies (31, 92) have emphasized repeatedly that this endothelial activity represents an important pharmacological target, this concept has not yet found wide acceptance. Thus, while in the context of the development of new antithrombotic medications great emphasis is currently being placed on development and clinical introduction of specific thrombin inhibitors (54, 55) , very little attention is being paid to sealing of the venular endothelium and hence shielding the coagulatory zymogens in plasma from the subendothelial pericytes with their highly concentrated tissue factor that plays the key role in triggering of intravasal coagulatory processes (14, 38, 48, 64) .
Identification of LTB 4 as a Mediator Deleterious to the Venular Barrier
Effect of ASA and inhibitors of leucotriene synthesis on the release of permeability-enhancing products from simultaneously activated platelets and PMN. The initial studies using ASA indicated that at least one major substance component, probably AA, was released selectively from activated platelets, which PMNs then used for the synthesis and release of at least one permeability-enhancing, stable derivative. The studies with the 5-LOX inhibitor ZD2138 or the FLAP inhibitor BAY-X-1007 indicated that the liberated compound was probably a leucotriene.
Effect of PAF and LTB 4 receptor antagonists. Application of the highly specific PAF antagonist 1-O-hexadecyl-2-acetyl-snglycero-3-phospho-(N,N,N,-trimethyl)hexanolamine (23) to the filtration medium indicated that PAF itself did not induce a prompt or statistically relevant enhancement of permeability of cultured human venular endothelial cells (Fig. 5, lane f and Fig.  8, top) . This finding agrees well with those of Curry et al. (17) but is in contrast to other findings on the biological effects of PAF (1, 95, 104) . It is well accepted, however, that PAF of platelet origin can increase production and release of LTA 4 in PMNs (44, 93) , which is a precursor of LTB 4 synthesis in endothelial cells (75) , erythrocytes (53) , and, to a minor extent, in the PMNs themselves (76) . This is consistent with the present results showing a greater influence of PMNs on the L P of SC-PVO during incubation with AA and PAF (see Fig. 1,  lane j) . In addition, it also appears reasonable that the concurrent presence of the LTB 4 receptor antagonist U-75302 and the above-mentioned PAF antagonist almost completely prevented the breakdown of the barrier function of SC-PVO in the presence of activated platelets and PMNs or their supernatant.
Eicosanoid production and release in SC-PVO cocultured with blood cells. Biochemical analyses strongly imply that LTB 4 is, in fact, a major release product of PMNs in coculture with SC-PVO, when the incubation medium is supplemented with AA and PAF (thus imitating the presence of activated platelets). The fact that considerably larger amounts of LTB 4 were produced under these conditions in the presence of red blood cells is in agreement with earlier studies (53) demonstrating LTB 4 synthesis by erythrocytes incubated with exogenous LXA 4 . Interestingly, these findings are also consistent with recent studies in the perfused mesenteric circulation in which hypoxia-induced inflammatory reactions were attributed to the simultaneous action of LTB 4 und PAF (16) .
In addition to LTB 4 , the prostanoids PGI 2 and PGE 2 are released in large amounts from activated SC-PVO. These products of the COS1 or 2, respectively, have long been recognized as typical endothelial products and strong platelet inhibitors (12) . PGE 2 has been reported to potentiate the effects of PAF (30) and to reduce endothelial barrier function (5), observations which could be confirmed by our own results (Fig. 8, top) .
Synergism Between Various Mediators of Venular Barrier Loss
Barriers formed by SC-PVO and exposed to various inflammatory mediators (PAF, PGE 2 , IL-6, and IL-8) separately or in combination showed characteristic concentration-dependent increases in L P , although the effects were significant only at concentrations far beyond their normal plasma concentrations. In combination with LTB 4 , however, a synergistic increase in action of this leucotriene was observed, which, in all probability, also explains the enormous in situ effect of subnanomolar concentrations of LTB 4 on perfused prepared microcirculation systems (77) . This effect of the IL-6 and IL-8 is especially interesting. Both peptides are now considered as particularly important participants of acute inflammatory tissue processes in which PMNs are involved (70, 86) .
Inhibitory Actions of Quercetin Glucuronide in the In Vitro Model of Acute Inflammation
High concentrations of flavonoids are found frequently as nonessential and healthy plant metabolites in foodstuffs and have attracted interest as natural inhibitors of inflammation (28, 50, 78) . A frequently occurring flavonoid is quercetin, which is readily absorbed in the duodenum and then coupled to uronic acid before its transport in plasma (98) .
QG is an effective inhibitor of platelet activation via the modulation of PAF synthesis and of glyocoprotein VI signaling pathway proteins (6, 99) . Moreover, flavonoids like QG have been characterized as efficient inhibitors of 5-LOX (83). In our studies, 100 M QG inhibited release of LTB 4 and PGE 2 , the former possibly reflecting the inhibitory effect of flavonoids on 5-LOX and the latter by the inhibitory effect on platelets. A direct inhibitory effect of flavonoids on COX-2 has not yet been described and remains speculative.
A strong antioxidant effect has also been ascribed to flavonoid compounds (83) , and these compounds have been shown to enhance endothelial NO synthesis (58) . QG proved to be an effective antioxidant also in our studies. The inhibitory action of this QG with respect to the recruitment of actin and stress fibers of human postcapillary venular endothelial cells has already been discussed above.
The synergistic increase in endothelium-protective potency of QG by LXA 4 , described here for the first time, suggests that QG can act as an efficient inhibitor of platelet/neutrophilinduced edema formation already at relatively low plasma concentrations. LXA 4 at low, basal plasma concentration obviously plays a physiological role as a potent inhibitor of PMNs and in the context of resolution of inflammatory reactions in whole blood (22, 49, 80, 87) .
Segment-Specific Microvascular Segregation of Activated Platelets and PMNs During Perfusion of Human Hearts with Whole Blood
As noted earlier, a surprisingly selective segregation of the platelets in arterioles and of the PMNs in postcapillary venules was observed (Fig. 10) . In contrast, postcapillary venular endothelium under inflammatory conditions produces plasmalemmal and junctional leucocyte adhesion molecules enabling selective adhesion to and emigration of PMNs from venules (42, 46, 71, 101) . Indeed, such leucocytes accumulated abundantly in postcapillary venules and in the local myocardial interstitium around these smallest veins of the hearts investigated, while no wall-resident platelets were apparent. This probably reflects the selective capture of platelets in the corresponding upstream arterioles. The elevated formation and release of PGI 2 and PGE 2 by activated venular endothelium demonstrated in our study (Fig. 9B) , as well as the formation of adenosine from ADP via endothelial ecto-phosphatases may also, however, have contributed to the prevention of platelet segregation in the lumen of the myocardial venules in the isolated, blood-perfused hearts. The inhibition of platelet aggregation in the vicinity of postcapillary venular endothelium is also in good agreement with time-lapse microcinematographic studies on the respective cellular interactions under defined in vitro conditions (Fig. 3 and Supplemental Videos). Our observations with respect to selective arteriolar segregation of platelets are in contrast to interesting studies showing venular accumulation of platelets after ischemia/reperfusion in blood-perfused microvascular systems in situ (34, 71) . While ϳ25% of the platelets were bound directly to the endothelium, most of the remainder (75%) were bound to PMNs, which might strongly enhance both the metabolic cooperation between these cells and the generation of ROS (71) . This cellular interaction probably began already during the ischemia. In our model, however, the platelets encountered the preactivated human arteriolar endothelium abruptly, which obviously reacted by recruitment of vWF:Ag from its particularly numerous Weibel-Palade bodies (see above).
The fact that very similar histological results were obtained when only the platelets were initially activated with exogenous ADP showed that their activation and accumulation in the arterioles of blood-perfused, ischemic hearts will lead spontaneously to the coactivation of PMNs and the venular endothelium. This is very probably initiated by PAF released from the platelets (as shown in Fig. 11) .
The fact that (regardless of the activation protocol for the PMNs via FMLP) 50 M QG completely prevented platelet adhesion and aggregation in the arterioles is consistent with the array of inhibitory actions of this flavonoid discussed above. In addition, these findings could also indicate that the recruitment of p-selectin from Weibel-Palade bodies is specifically inhibited in the arteriolar endothelium by the flavonoid. While the chain of metabolic events leading to the release of PAF and AA from platelets and the coactivation of PMNs and red blood cells to produce LTB 4 should have also been prevented in these hearts (see Fig. 11 ), the PMNs could still be effectively activated by FMLP. The fact that they then selectively adhered to postcapillary endothelium and emigrated into the myocardial tissue indicates that QG does not on principle impair the important recruitment of these cells for immunological defense purposes.
Synopsis and Physiological Relevance of the Investigated Biochemical Interactions
The newly gained insights into the cellular and molecular interactions of endothelial cells, platelets, PMN, and erythrocytes are outlined in Fig. 11 . This scheme also shows the approaches employed in the experiments with inhibitors to elucidate the reactions.
In the vascular outflow from inflamed tissue areas (not shown in Fig. 11 ), the presence of PAF and LTB 4 will be counteracted in the venous blood by endothelium-derived au- Fig. 11 . Scheme of the biochemical and cellular mechanisms proposed to be responsible for the breakdown of the venular endothelial barrier and possible pharmacological intervention. Locally released inflammatory mediators activate the arteriolar endothelium, resulting in the adhesion/aggregation of platelets. PAF released from these platelets activates the arteriolar endothelium further as well as incoming PMN. The latter synthesize leucotriene LTA4 from AA (also released by the platelets). LTA4 is metabolized by erythrocytes and endothelial cells to LTB4, which in turn activates, via specific receptors, the postcapillary venular endothelium. Via complex signal cascades this results, among other enzyme systems, in activation of the myosin light chain kinase (MLCK), contraction of the VEC and widening of the intercellular junctions and hence breakdown of the blood-myocardium barrier. Plasma now flowing into the subendothelial space encounters the pericytes (for the consequences of this, see text). Approaches for pharmacological intervention include 1: platelet inhibition by ASA; 2: blockade of the PAF receptor by an antagonist; 3: inhibition of FLAP; 4: inhibition of 5-lipoxygenase; 5: antagonism LTB4 binding to its endothelial receptor; 6: intervention (complex) in the actin polymerization process; and 7: antioxidants against reactive oxygen species (ROS) released by activated PMN. tacoids such as adenosine, NO, PGI 2 , and PGE 2 that are secreted at higher concentrations under these circumstances. These platelet inhibitors also act as potent vasodilators and are therefore very probably mainly responsible for the hyperemic response in the circumference of inflammatory foci. Further downstream in the collecting veins all these compounds are diluted rapidly and are increasingly eliminated by catabolic blood-borne enzymes (PAF, LTB 4 , adenosine, and PGE 2 ) or due to their high innate chemical reactivity (NO) or thermal instability (PGI 2 ). Correspondingly, the macroscopically evident redness of the hyperemic ring around a typical inflammatory focus, and with it the increased perfusion of the microcirculatory system of this area, diminishes increasingly towards the periphery.
To prevent the penetration of activated defense cells and plasma factors into the remaining circulatory system, it seems also appropriate for the body to isolate an excessive inflammatory focus in the area of its venular outflow. Hence, the release of LTB 4 and PAF and the resulting opening of the venular endothelial barrier not only serve to recruit immunological defense systems but also to activate the coagulation cascade via tissue factor (48, 68) that is expressed particularly on pericytes (14, 38, 64, 97) and that come in direct contact with the zymogens of coagulation in the inflammatory plasma exudate.
Perspectives
The substantial differences in barrier behavior seen in the arteriolar and venular vessel wall models in the present study in response to components of the coagulation or nonspecific immune systems, extrapolated to the intact coronary microcirculation in vivo, strongly imply a key role for the postcapillary venules in myocardial injury or inflammatory processes. Despite their thin walls and loosely organized endothelial cell junctions (18, 84, 85, 96) , healthy coronary venules are remarkably tight. This can, however, change drastically on activation, and these specialized vessels can become the hot spots of inflammatory edema, defense processes, and fibrin thrombi. Interventional strategies to prevent the spread of these processes, initially local and aimed at limiting inflammatory reactions and injuries, should primarily address the repair of the damaged blood-myocardium barrier, in particular the venular tightness. In this respect, the mechanism of action of QG and structure/function-relationships needs further elucidation. Promising studies in this direction are the systematic study of quercetin and its derivatives as inhibitors of platelets (99) , and the effectiveness of certain polyphenoles, like the flavonoids, as therapeutic agents in systemic sepsis (81) . In this illness, activated platelets, PMNs, and the breakdown of the venular barrier in many organs are of key pathogenic importance.
In studies on other blood-organ barriers, including the wellknown blood-brain barrier, focusing on the functionally versatile and complexly controlled venular barrier rather than on purely structural aspects might yield new insights.
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